VentriPoint Diagnostics Current Valuation vs. Shares Owned By Insiders
| VPT Stock | CAD 0.10 0.01 11.11% |
For VentriPoint Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of VentriPoint Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well VentriPoint Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between VentriPoint Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of VentriPoint Diagnostics over time as well as its relative position and ranking within its peers.
VentriPoint |
VentriPoint Diagnostics Shares Owned By Insiders vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining VentriPoint Diagnostics's current stock value. Our valuation model uses many indicators to compare VentriPoint Diagnostics value to that of its competitors to determine the firm's financial worth. VentriPoint Diagnostics is rated first in current valuation category among its peers. It is rated first in shares owned by insiders category among its peers . The ratio of Current Valuation to Shares Owned By Insiders for VentriPoint Diagnostics is about 8,276,191 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VentriPoint Diagnostics' earnings, one of the primary drivers of an investment's value.VentriPoint Current Valuation vs. Competition
VentriPoint Diagnostics is rated first in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 1.69 Billion. VentriPoint Diagnostics claims roughly 17.3 Million in current valuation contributing just under 2% to equities under Health Care industry.
VentriPoint Shares Owned By Insiders vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
VentriPoint Diagnostics |
| = | 17.3 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
VentriPoint Diagnostics |
| = | 2.09 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
VentriPoint Shares Owned By Insiders Comparison
VentriPoint Diagnostics is currently under evaluation in shares owned by insiders category among its peers.
VentriPoint Diagnostics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in VentriPoint Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, VentriPoint Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of VentriPoint Diagnostics' change in net profit over the period of time. It can combine multiple indicators of VentriPoint Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 93.1 K | 80.9 K | |
| Operating Income | -4.9 M | -4.7 M | |
| Net Loss | -4.9 M | -4.6 M | |
| Income Tax Expense | 3.00 | 2.85 | |
| Income Before Tax | -4.9 M | -5.1 M | |
| Total Other Income Expense Net | 58.6 K | 55.6 K | |
| Net Loss | -4.9 M | -4.6 M | |
| Net Loss | -2.1 M | -2.2 M | |
| Net Interest Income | 10.1 K | 10.6 K | |
| Interest Income | 76.6 K | 45.4 K | |
| Change To Netincome | 658.3 K | 691.2 K | |
| Net Loss | (0.03) | (0.03) | |
| Income Quality | 0.78 | 0.71 | |
| Net Income Per E B T | 0.99 | 0.81 |
VentriPoint Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on VentriPoint Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of VentriPoint Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the VentriPoint Diagnostics' important profitability drivers and their relationship over time.
Use VentriPoint Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VentriPoint Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VentriPoint Diagnostics will appreciate offsetting losses from the drop in the long position's value.VentriPoint Diagnostics Pair Trading
VentriPoint Diagnostics Pair Trading Analysis
The ability to find closely correlated positions to VentriPoint Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VentriPoint Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VentriPoint Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VentriPoint Diagnostics to buy it.
The correlation of VentriPoint Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VentriPoint Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VentriPoint Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VentriPoint Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your VentriPoint Diagnostics position
In addition to having VentriPoint Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Moderate Funds Thematic Idea Now
Moderate Funds
Funds or Etfs that combine stocks, bonds and money market instruments to get modest capital appreciation over time. The Moderate Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Moderate Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.